Atlas Trials

Study to Assess the Safety and Tolerability of Single Doses of REGN1500

Clinical trial NCT01749878 · COMPLETED

Trial details

NCT number
NCT01749878
Sponsor
Regeneron Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypertriglyceridemia
Start date
2012-12-01
Primary completion
2016-01-01
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.